Furthermore, low MTSS1 expression was associated with an increased risk of relapse in pediatric AML [27], and with poor overall survival in a cohort of adult patients with cytogenetically normal AML [44]. The gene discussed is MTSS1; the disease is acute myeloid leukemia.